trending Market Intelligence /marketintelligence/en/news-insights/trending/_ijgNv-ixH2JQT-fmRJVvA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

CanniMed receives Health Canada's approval to produce medical cannabis capsules

Blog

M&A rebound sparks optimism for near-term deal activity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud


CanniMed receives Health Canada's approval to produce medical cannabis capsules

Health Canada granted CanniMed Therapeutics Inc. license to produce medical cannabis capsules.

The company has initiated production of its CanniMed capsules following receipt of the production license.